Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells & Cell Therapy Summit

Wei (Eric) Wang's Biography



Wei (Eric) Wang, Attending Doctor, Daping Hospital, Third Military Medical University

Education:
11/2008-04/2010 Postdoctoral Fellow
Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA, USA
03/2008-10/2008 Postdoctoral Fellow
Department of Surgery, UMDNJ-New Jersey Medical School, Newark, NJ, USA
09/2005-07/2010 Ph.D.
Institute of Burn Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China
09/2000-07/2005 M.D.
Clinical Medicine, Third Military Medical University, Chongqing, China
Research Experience:
08/2010-present Principle Investigator
Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China
Stem cell therapy for myocardial infarction, supported by National Natural Science Foundation of China.

Wei (Eric) Wang Image

PHD2 Silencing Enhances the Survival and Paracrine Function of Transplanted Adipose-Derived Stem Cells in Infarcted Myocardium

Friday, 6 September 2013 at 16:15

Add to Calendar ▼2013-09-06 16:15:002013-09-06 17:15:00Europe/LondonPHD2 Silencing Enhances the Survival and Paracrine Function of Transplanted Adipose-Derived Stem Cells in Infarcted MyocardiumStem Cells and Cell Therapy Summit in London, UKLondon, UKSELECTBIOenquiries@selectbiosciences.com

Silencing prolyl hydroxylase domain protein 2 (PHD2) promotes the survival of transplanted adipose-derived stem cells (ADSCs) in infarcted hearts and enhances their paracrine function. The promoted survival was HIF-1alpha dependent, while the enhanced paracrine function was associated with NF-kB signaling.


Add to Calendar ▼2013-09-05 00:00:002013-09-06 00:00:00Europe/LondonStem Cells and Cell Therapy SummitStem Cells and Cell Therapy Summit in London, UKLondon, UKSELECTBIOenquiries@selectbiosciences.com